Semaglutide and Other GLP-1 Agonists: A Boon for the Arthroplasty Industry?
Matthew L. Magruder, David Jacofsky, Bryan D. Springer, Giles R. Scuderi, Daniel Hameed, Michael A. Mont
Topics & Concepts
MedicineObesitySemaglutideContraindicationPopulationPrediabetesHealth careDiabetes mellitusDisease controlGerontologyDemographyInternal medicineFamily medicineType 2 diabetesEnvironmental healthEndocrinologyAlternative medicinePolitical scienceLiraglutideLawSociologyPathologyDiabetes Treatment and ManagementPharmacology and Obesity TreatmentMetabolism, Diabetes, and Cancer